China's First 3D Printed Drug Files for Market Approval

October 2, 2025 Applications 153

On September 28, Triastek's 3D printed drug T20J (Apixaban Tablets) submitted its market application, marking the first 3D printed drug in China to seek regulatory approval.

The product has completed process validation and bioequivalence (BE) studies, and has obtained the nation's first production license for 3D printed pharmaceuticals. Additionally, Triastek has five other 3D printed drugs in clinical stages, all utilizing its proprietary MED (Melt Extrusion Deposition) technology.

News
About
Events
Newsletter
Research

Podcast
Zones
Forum
Shop
Contact

Advertise
Additive Manufacturing
3D Printing
Industry Directory

Global Offices

U.S. Headquarters
Address: 2595 Pomona Blvd, Pomona, CA 91768, USA
Email: bjldid@gmail.com
Jason

China Office
Address: Room 401, Block C, Zhongguancun Zhizao Avenue, No. 45 Chengfu Road, Haidian District, Beijing, China 100083
Email: bjldid@126.com
Gwen wechat: scrat3dcom